Latest Prothrombin time Stories
MENLO PARK, Calif., May 8, 2015 /PRNewswire/ -- Armetheon, Inc., a specialty pharmaceutical company developing novel small molecule drugs for cardiovascular diseases, today announced the appointment
Study Finds Kcentra® is Superior to Plasma in Patients Needing Warfarin Reversal for Urgent Surgical or Invasive Procedures KING OF PRUSSIA, Pa., March 17, 2015 /PRNewswire/ --
Dr. Larry Hsu Elected to Board of Directors MENLO PARK, Calif., Feb.
Healthcare Professionals and Patient Self-Testers Should Not Use the INRatio® and INRatio®2 PT/INR Monitor System with Certain Medical Conditions WALTHAM, Mass., Dec.
The anti-stroke combination treatment may increase dementia risks in patients with irregular heart rhythm, atrial fibrillation. Port Washington, New York (PRWEB)
LONDON, June 11, 2014 /PRNewswire/ -- Reportbuyer.com has added a new market research report:
A new study by researchers at the Intermountain Medical Center Heart Institute in Salt Lake City has found that atrial fibrillation patients who are on blood thinning medications are at higher risk of developing dementia if their doses are not in the optimal recommended range.
Healthcare Professionals Should Stop Using Strips WALTHAM, Mass., May 6, 2014 /PRNewswire/ -- Alere Inc. (NYSE: ALR) has initiated a voluntary Class 1 recall in the U.S.
Recently Released ACC/AHA Practice Guidelines Reinforce Unmet Need MENLO PARK, Calif., April 29, 2014 /PRNewswire/ -- Armetheon, Inc., today announced that it has reached agreement
Results Show Highest Rate of Control Ever Observed with Warfarin in Real-world Setting, Surpassing Thresholds for Cost-Effectiveness of Newer Agents Identified in Five Recent Independent Studies
- A woman chauffeur.
- A woman who operates an automobile.